Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI

Delayed Quote. Delayed  - 05/24 05:19:04 pm
1.55 USD   +0.32%
05/20 PLURISTEM THERA : Completes Enrollment of 150 Patients in Phase II I..
05/17 PLURISTEM THERA : Completes Enrollment of 150 Patients in Phase II I..
05/16 PLURISTEM THERA : Completes Enrollment of 150 Patients in Phase II I..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2016 05/19/2016 05/20/2016 05/23/2016 05/24/2016 Date
1.52(c) 1.41(c) 1.49(c) 1.545(c) 1.55 Last
132 736 278 638 114 867 210 293 12 164 Volume
-4.40% -7.24% +5.67% +3.69% +0.32% Change
More quotes
Financials ($)
Sales 2016 2,85 M
EBIT 2016 -24,7 M
Net income 2016 -23,7 M
Debt 2016 -
Yield 2016 -
Sales 2017 0,93 M
EBIT 2017 -30,3 M
Net income 2017 -27,9 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 43,5x
Capi. / Sales 2017 133x
Capitalization 124 M
More Financials
Company
Pluristem Therapeutics, Inc. engages in the development of standardized cell therapy products for the treatment of life threatening diseases.Its patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a variety of local and systemic... 
More about the company
Surperformance© ratings of Pluristem Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on PLURISTEM THERAPEUTICS INC
05/20 PLURISTEM THERAPEUTICS : Completes Enrollment of 150 Patients in Phase II Interm..
05/17 PLURISTEM THERAPEUTICS : Completes Enrollment of 150 Patients in Phase II Interm..
05/16 PLURISTEM THERAPEUTICS : Completes Enrollment of 150 Patients in Phase II Interm..
05/10 PLURISTEM THERAPEUTICS : Reports Third Quarter Fiscal 2016 Financial Highlights ..
05/09 BRIEF : Israeli stem cell co Pluristem receives $3.3m grant
05/09 Pluristem Awarded $3.3 Million Grant by Israeli Government
04/22 PLURISTEM THERAPEUTICS : Enters Into Licensing Agreement with TES Holdings Co., ..
04/21 Pluristem Enters into Licensing Agreement with TES Holdings Co., Ltd., a vent..
More news
Sector news : Biotechnology & Medical Research - NEC
04:16pDJNant Health Seeks $82 Million in IPO
01:02p ALKERMES : to Present Data on ALKS 5461 at Upcoming American Society of Clinical..
05/23 AMGEN : Senior Leaders Advance Discussion on Cancer at 2016 World Medical Innova..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/10 Pluristem Therapeutics EPS in-line
04/13 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
02/22 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
02/17 Pluristem adds to up move stoked by improved prospects for PLX-R18; shares up..
02/17 Midday Gainers/ Losers


Comments 
Advertisement
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Technical analysis trends PLURISTEM THERAPE...
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions